PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11880373-3	2002	We found that enalaprilat and other ACE inhibitors in nanomolar concentrations activate human bradykinin B(1) receptors directly in the absence of ACE and the B(1) agonist des-Arg(10)-Lys(1)-bradykinin.	des-arg	172-179	angiotensin I converting enzyme	Homo sapiens	36-39	
24816436-11	2014	Intake of ACE inhibitors and statins associated with metabolites that provide insight into the action of the drug itself on its target, such as an association of ACE inhibitors with des-Arg(9)-bradykinin and aspartylphenylalanine, a substrate and a product of the drug-inhibited ACE.	des-arg	182-189	angiotensin I converting enzyme	Homo sapiens	10-13	
24816436-11	2014	Intake of ACE inhibitors and statins associated with metabolites that provide insight into the action of the drug itself on its target, such as an association of ACE inhibitors with des-Arg(9)-bradykinin and aspartylphenylalanine, a substrate and a product of the drug-inhibited ACE.	des-arg	182-189	angiotensin I converting enzyme	Homo sapiens	162-165	
24816436-11	2014	Intake of ACE inhibitors and statins associated with metabolites that provide insight into the action of the drug itself on its target, such as an association of ACE inhibitors with des-Arg(9)-bradykinin and aspartylphenylalanine, a substrate and a product of the drug-inhibited ACE.	des-arg	182-189	angiotensin I converting enzyme	Homo sapiens	162-165	
17372720-2	2007	The aim of the present study was to evaluate, by means of functional studies in a capacitance vessel such as the human umbilical vein (HUV), the possible role played by the metallopeptidases angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP), and aminopeptidase M (APM) as an inactivating pathway of the B(1) receptor endogenous agonist des-Arg(10)-kallidin (DAKD).	des-arg	351-358	angiotensin I converting enzyme	Homo sapiens	222-225	
11406494-2	2001	The potentiating effect of an angiotensin-converting enzyme (ACE) inhibitor was, however, more extensive for BK (9.0-fold) than for des-Arg(9)-BK (2.2- fold).	des-arg	132-139	angiotensin I converting enzyme	Homo sapiens	30-59	
11406494-2	2001	The potentiating effect of an angiotensin-converting enzyme (ACE) inhibitor was, however, more extensive for BK (9.0-fold) than for des-Arg(9)-BK (2.2- fold).	des-arg	132-139	angiotensin I converting enzyme	Homo sapiens	61-64